XENETIC BIOSCIENCES INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$2.05
-3.30%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-8.5%
3 months
-22.9%
6 months
-31.0%
1 year
-37.7%
Year to date
-5.5%
52-week range
$1.72 – $4.67
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$4.8M
P/E
-1.9
P/B
0.8
P/S
1.5
Revenue
$3.26M
Net income
-$2.48M
Diluted EPS
-1.16
Gross margin
100.00%
Net margin
-75.90%
Return on equity
-40.60%
Total debt
$0
Cash
$6.47M
Free cash flow
-$2.31M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $660.6K | -$929.7K | 100.00% | -140.70% | -$875.49K |
| Mar 31, 2026 | $806.92K | -$456.38K | 100.00% | -56.60% | -$536.38K |
| Dec 31, 2025 | $766.3K | -$579.08K | 100.00% | -75.60% | -$242.68K |
| Sep 30, 2025 | $1.03M | -$509.94K | 100.00% | -49.70% | -$658.25K |
| Jun 30, 2025 | $589.9K | -$688.7K | 100.00% | -116.70% | -$383.83K |
| Mar 31, 2025 | $593.26K | -$903.14K | 100.00% | -152.20% | -$1M |
| Dec 31, 2024 | $648.82K | -$1.05M | 100.00% | -162.50% | -$673.99K |
| Sep 30, 2024 | $614.24K | -$436.67K | 100.00% | -71.10% | -$459.04K |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent XBIO news
All market newsNo ticker-linked stories are in the current archive.